West Pharmaceutical Services | WST - Cost Of Sales

Stock Price
304.41
Daily Change
1.52 0.50%
Monthly
9.50%
Yearly
40.14%
Q2 Forecast
296.80

West Pharmaceutical Services reported $548.5M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Align Technology USD 303.5M 60.47M Mar/2026
Avanos Medical USD 88M 6.9M Mar/2026
Baxter International USD 1.81B 587M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Cerus USD 23.42M 3.61M Dec/2024
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Cooper Companies USD 376.8M 87.4M Dec/2025
Dentsply International USD 453M 65M Mar/2026
Haemonetics USD 136.58M 4.01M Dec/2025
ICU Medical USD 337.72M 1.61M Dec/2025
Insulet USD 232.7M 17.5M Mar/2026
Integra LifeSciences USD 178.71M 14.73M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
J&J USD 8.07B 103M Mar/2026
Medtronic USD 3.61B 83M Dec/2025
Merit Medical Systems USD 197.08M 1.5M Mar/2026
Neogen USD 112.2M 5.81M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Quidel USD -79.5M 528.3M Mar/2026
Repligen USD 85.97M 8.11M Mar/2026
Rockwell Medical USD 21.28M 1.67M Jun/2024
Solventum Corp USD 911M 60M Mar/2026
STAAR Surgical USD 24.66M 10.6M Mar/2026
Terumo JPY 151.3B 7.86B Mar/2026
Utah Medical Products USD 3.78M 419K Dec/2025
West Pharmaceutical Services USD 548.5M 47.4M Mar/2026